Title : The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.

Pub. Date : 2016

PMID : 27904766






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma. ibrutinib ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens
2 A phase 1/2 clinical trial of single-agent ibrutinib in relapsed and refractory DLBCL patients revealed an overall response rate of 37% in ABC-DLBCL patients. ibrutinib ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens
3 Here we report the discovery of point mutations within the kinase PIM1 that reduce sensitivity to ibrutinib in ABC-DLBCL. ibrutinib ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens
4 The introduction of mutant PIM1 into an ABC-DLBCL cell line, TMD8, increased colony formation and decreased sensitivity to ibrutinib. ibrutinib ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens